Axillary Hyperhidrosis Epidemiology

Key Highlights

• Characterized by excessive underarm sweating, axillary hyperhidrosis is an uncontrollable, annoying, and embarrassing problem. It has a huge impact on one’s mental and physical health and professional life.
• Hyperhidrosis is categorized as either primary or secondary hyperhidrosis. Primary hyperhidrosis is idiopathic and is localized in a bilateral and symmetrical pattern affecting the axilla, palms, soles, and face. Secondary hyperhidrosis is usually focal or generalized due to underlying medical conditions.
• The diagnosis of axillary hyperhidrosis is established by the “Diagnostic criteria for diagnosing primary focal hyperhidrosis” in managing and treating axillary hyperhidrosis; the goal is to reduce sweat production and sweat glands. The Hyperhidrosis Disease Severity Scale (HDSS) helps gauge the impact of the disorder on the patient’s life, plan the treatment modality, and gauge the response to treatment and get disability compensation.
• Regarding the epidemiology of Axillary Hyperhidrosis, in 2022, it was found that the United States accounted for ~39% of the total diagnosed prevalant cases of axillary hyperhidrosis in the 7MM.
• Among the EU4 countries, the least number of diagnosed prevalent cases of axillary hyperhidrosis were found in Spain, i.e., ~204,000 cases in the year 2022. These cases are expected to increase by 2034.
• The high cost and prolonged treatment for axillary hyperhidrosis limit access to the condition. Insurance plans are complex and difficult to comprehend. Excessive sweating is dangerous and negatively influences the quality of life and ability to function properly.

DelveInsight’s “Axillary Hyperhidrosis – Epidemiology Forecast – 2034” report delivers an in-depth understanding of the Axillary Hyperhidrosis, historical and forecasted epidemiology in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Geography Covered

• The United States
• EU4 (Germany, France, Italy, and Spain) and the United Kingdom
• Japan

Study Period: 2021-2034

Axillary Hyperhidrosis Understanding and Diagnostic Algorithm

Axillary Hyperhidrosis Overview

Axillary hyperhidrosis, characterized by excessive underarm sweating, is an uncontrollable, annoying, embarrassing, and isolating problem. It has a significant effect on one’s psychological and physical health, as well as one’s occupational life. From the discomfort of sweat running down one’s sides to the embarrassment of obvious sweat stains to the fear of being “discovered,” uncontrollable underarm sweating can often feel like ruining one’s life.

Further details related to overview are provided in the report…

Axillary Hyperhidrosis Diagnosis

The first step in evaluating hyperhidrosis is differentiating between generalized and focal hyperhidrosis. Generalized hyperhidrosis is part of some other underlying condition, such as an infective or malignant disease or a hormonal disorder, and focal or primary idiopathic hyperhidrosis occurs in otherwise healthy people. Until recently, there have been only three ways of establishing a diagnosis of primary focal hyperhidrosis. These include Gravimetric testing, Minor-starch-iodine test, and Ninhydrin test.

Unlock comprehensive insights! Click Here to Purchase the Full Market Report @ Axillary Hyperhidrosis Treatment Market Size

Axillary Hyperhidrosis Epidemiology

The Axillary Hyperhidrosis epidemiology chapter in the report provides historical as well as forecasted epidemiology segmented by Total Diagnosed Prevalent Cases of Hyperhidrosis (HH), Total Diagnosed Prevalent Cases of Axillary Hyperhidrosis (AHH), Type-specific Cases of Axillary Hyperhidrosis (AHH), Age-specific Cases of Axillary Hyperhidrosis (AHH), and Severity-specific Cases of Axillary Hyperhidrosis (AHH) in the 7MM covering the United States, EU4 countries (Germany, France, Italy, Spain) and the United Kingdom, and Japan from 2021 to 2034.

• The United States accounted for ~3,441,000 diagnosed prevalent cases of axillary hyperhidrosis in 2022, which is projected to increase during the forecast period (2025-2034).
• The total diagnosed prevalent cases of axillary hyperhidrosis in EU4 and the UK were ~3,045,000 in 2022. The cases will increase during the forecast period (2025-2034).
• The total diagnosed prevalent cases of axillary hyperhidrosis in Japan were ~2,377,000 in 2022.
• The Germany accounted for the highest number of diagnosed prevalent cases in EU4 and the UK, which were ~23% of the total diagnosed prevalent cases in the 7MM

Scope of the Report

• The report covers a segment of key events, an executive summary, and a descriptive overview of axillary hyperhidrosis, explaining its etiology, risk factors, pathophysiology, and diagnosis.
• Comprehensive insight into the country-wise epidemiology segments and forecasts, the future growth potential of diagnosis rate, and insights on disease progression have been provided.
• Patient stratification based on type, age, and severity is an inclusion
• A detailed review of current challenges in establishing diagnosis

Axillary Hyperhidrosis Report Insights

• Axillary Hyperhidrosis Patient Population
• Type-specific, Age-specific and Severity-specific Distribution in Axillary Hyperhidrosis
• Country-wise Epidemiology Distribution

Axillary Hyperhidrosis Report Key Strengths

• 10 year Forecast
• The 7MM Coverage
• Axillary Hyperhidrosis Epidemiology Segmentation

Axillary Hyperhidrosis Report Assessment

• Epidemiology Segmentation
• Current Diagnostic Practices

Take Your Research to the Next Level! Click Here to Get Access to the Full Pipeline Report @ Axillary Hyperhidrosis New Medications

Key Questions

Epidemiology Insights

• What are the disease risks, burdens, and unmet needs of axillary hyperhidrosis? What will be the growth opportunities across the 7MM with respect to the patient population of axillary hyperhidrosis?
• What is the historical and forecasted axillary hyperhidrosis patient pool in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan?
• Which age group is the largest contributor to the axillary hyperhidrosis patient pool?
• Which type has the most number of cases of axillary hyperhidrosis in the 7MM?

Reasons to Buy

• Insights on disease burden, details regarding diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand the change in axillary hyperhidrosis cases in varying geographies over the coming years.
• Detailed overview on type-specific, age-specific and severity-specific cases of axillary hyperhidrosis is included.
• To understand the perspective of key opinion leaders around the current challenges with establishing the diagnosis and insights on the treatment-eligible patient pool.
• Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.

Click here to Read More about the Related Articles:- Latest DelveInsight Blogs